{
    "root": "dccc65f9-2984-4049-a125-06ff28498297",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ibuprofen",
    "value": "20250213",
    "ingredients": [
        {
            "name": "IBUPROFEN",
            "code": "WK2XYI10QM"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Carefully consider the potential benefits and risks of Ibuprofentablets and other treatment options before deciding to use Ibuprofen.Use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see \n                        WARNINGS\n                     ).\n                  Ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.\n                  Ibuprofen tablets are indicated for relief of mild to moderate pain.\n                  Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea.\n                  Controlled clinical trials to establish the safety and effectiveness of Ibuprofen tablets in children have not been conducted.",
    "contraindications": "Carefully consider the potential benefits and risks of Ibuprofen tabletsand other treatment options before deciding to use Ibuprofen tablets. Usethe lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see \n                        WARNINGS\n                     ).\n                  After observing the response to initial therapy with Ibuprofen tablets, thedose and frequency should be adjusted to suit an individual patient’sneeds.Do not exceed 3200 mg total daily dose. If gastrointestinal complaintsoccur, administer Ibuprofen tablets with meals or milk.",
    "warningsAndPrecautions": "Ibuprofen tablets are available in the following strengths, colors and sizes:\n                  400 mg : Oval shaped, white, film-coated tablet debossed \"4I\" on one side. \n                  Cartons of 100 tablets (10 tablets each blister pack x 10), NDC 0904-5853-61\n                  Bottles of 100 tablets, NDC 0904-5853-60\n                  Bottles of 500 tablets, NDC 0904-5853-40\n                  600 mg : Caplet shaped, white, film-coated tablet Debossed \"6I\" on one side. \n                  Cartons of 100 tablets (10 tablets each blister pack x 10), NDC 0904-5854-61\n                  Bottles of 100 tablets, NDC 0904-5854-60\n                  Bottles of 500 tablets, NDC 0904-5854-40\n                  800 mg : Caplet shaped, white, film-coated tablet debossed \"8I\" on one side.\n                  Cartons of 100 tablets (10 tablets each blister pack x 10), NDC 0904-5855-61\n                  Bottles of 100 tablets, NDC 0904-5855-60\n                  Bottles of 500 tablets, NDC 0904-5855-40\n                  Store at room temperature. Avoid excessive heat 40°C (104°F).\n                  Distributor: \n                  \n                     Dr. Reddy’s Laboratories Inc.,\n                  \n                  Princeton, NJ 08540 \n                  \n                     Packaged and Distributed by:\n                  \n                  \n                     MAJOR® PHARMACEUTICALS\n                  \n                  Indianapolis, IN 46268 USA\n                  Refer to package label for Distributor's NDC Number\n                  \n                     Made in India \n                  \n                  Revised: 07/2024",
    "adverseReactions": "Ibuprofen tablets are contraindicated in patients with known hypersensitivityto ibuprofen.\n                  Ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin orother NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see \n                        WARNINGS, Anaphylactoid Reactions, and PRECAUTIONS, Preexisting Asthma).\n                  \n                  Ibuprofen tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery(see \n                        WARNINGS\n                     )."
}